Cyclosporine pharmacokinetics

Busnach, G. et al., Effect of n-3 polyunsaturated fatty acids on cyclosporine pharmacokinetics in kidney graft recipients A randomized placebo-controlled study, J Nephrol, 11, 87, 1998. [Pg.203]

Min DI, Ku YM, Perry PJ, et al. Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients. Transplantation 1996 62(1) 123-125. [Pg.188]

Mueller, E.A. et al. (1994a) Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation.Pharm. Res., 11 301-304. [Pg.252]

Chang, T., L. Z. Benet, and M. F. Hebert. 1996. The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy voluntee 8in Pharmacol The69 297-303. [Pg.527]

Kovarik, J.M., et al. 1994. Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. J Pharm Sci 83 444. [Pg.129]

J. M. Kovarik, E. A. Mueller, J. B. van Bree, W. Tetzloff, and K. Kutz, Reduced inter and intraindividual variability in cyclosporine pharmacokinetics form a microemulsion formulation, J. Pharm. Sci. 83 444-446 (1994). [Pg.131]

Min DI, Ellingrod VL. C3435T mutation in exon 26 of the human MDR1 gene and cyclosporine pharmacokinetics in healthy subjects. Ther Drug Monit 2002 24 400-404. [Pg.143]

Cleary JD, Davis G, Raju S. Cyclosporine pharmacokinetics in a lung transplant patient undergoing hemofiltration. Transplantation 1989 48 710-2. [Pg.71]

Couet W, Istin B, Seniuta P, Morel D, Potaux L, Fourtillan JB. Effect of ponsinomycin on cyclosporin pharmacokinetics. Eur J Clin Pharmacol 1990 39(2) 165-7. [Pg.2193]

BD. 1992. Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia racial differences in bioavailability. Clin. Pharmacol. Ther. 52 359-71... [Pg.304]

Cooney GF, Habucky K, Hoppu K. Cyclosporin pharmacokinetics in paediatric transplant recipients. Clin Pharmacokinet 1997 32 481-495. [Pg.251]

RG Buice et al. Analytical methodologies for cyclosporine pharmacokinetics—A comparison of radioimmunoassay with high performance liquid chromatography. J Liq Chromatogr 10 421, 1987. [Pg.301]

CYP3A5 Tacrolimus Cyclosporine Pharmacokinetic parameters 3 (non-expressor) associated with higher trough plasma concentrations 43, 44... [Pg.73]

Buice, R.G. Stentz, F.B. Gurley, B.J. Anal3dical methodologies for cyclosporine pharmacokinetics A comparison of radioimmunoassay with high performance liquid chromatography. J.Liq.Chromatogr., 1987, 10, 421-438 [pharmacokinetics hile plasma serum dog]... [Pg.456]

BottorffMB, MarienML, ClendeningC. Macrolide antibiotics and inhibition of CYP3A isozymes differences in cyclosporin pharmacokinetics. CUn Pharm(K ol Ther 99T) 56,224. [Pg.1017]

Vemillet L, Bertault-Peres P, Berland Y, Barradas J, Durand A, Olmer M. Lack of effect of spiramycin on cyclosporin pharmacokinetics. BrJ Clin Pharmacol (1989) 27, 789-94. [Pg.1017]

Van Buren DH, Koestner J, Adedoyin A, McCune T, MacDonell R, Johnson HK, Carroll J, Nylander W, Richie RE. Effect of ciprofloxacin on cyclosporine pharmacokinetics. Transplantation (1990) 50, 888-9. [Pg.1019]

McLachlan AJ, Tett SE. Effect of metabolic inhibitors on cyclosporine pharmacokinetics using a population approach. Ther Drug Monit (199S) 20,390-5. [Pg.1025]

Jones TE, Morris RG, Mathew TH. Diltiazem-cyclosporin pharmacokinetic interaction — dose-response relationship. BrJ Clin Pharmacol (1997) 44, 499-504. [Pg.1028]

Koneru B, Hartner C, I watsuki S, Starzl TE. Effect of danazol on cyclosporine pharmacokinetics. Transplantation (1988) 45,1001. [Pg.1032]

Yee GC, Adams VR, Pessa L, BraddockRJ, Ruiz J, Lowenthal DT. Comparison of one versus two doses of grapefruit juice on oral cyclosporine pharmacokinetics. Pharmacoffiercqry... [Pg.1035]

Tsang VT, Johnston A, Heritier F, Leaver N, HodsonME, YacoubM Cyclosporin pharmacokinetics in heart-lung transplant recipients with cystic fibrosis. Fur J CUn Pharmacol (1994) 46, 261-5. [Pg.1036]

Jensen P, Lehne G, FauchaldP, Simonsen S. Effect of oral terbinafine treatment on cyclosporin pharmacokinetics in organ transplant recipients with dermatophyte nail infection. Acta Derm Venereol (Stockh) (1996) 76, 280-1. [Pg.1048]

Taylor PJ, Kubler PA, Lynch SV, Allen J, Butler M, Pillans PI. Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients. Ann Pharmacother (2004) 38, 205-8. [Pg.1098]

Cassem JD, Hamilton MA, Albanese E, Sabad A, Kobaidiigawa JA. Does pravastatin affect cyclosporine pharmacokinetics in cardiac transplant recipients. J Investig Med (1997) 45,... [Pg.1098]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...